1. Home
  2. SQNS vs ADAG Comparison

SQNS vs ADAG Comparison

Compare SQNS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$5.00

Market Cap

85.3M

Sector

Technology

ML Signal

HOLD

Logo Adagene Inc.

ADAG

Adagene Inc.

HOLD

Current Price

$1.80

Market Cap

84.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
ADAG
Founded
2003
2011
Country
France
China
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
85.3M
84.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
SQNS
ADAG
Price
$5.00
$1.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$21.33
$8.00
AVG Volume (30 Days)
156.4K
44.4K
Earning Date
02-10-2026
08-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,534,000.00
$103,204.00
Revenue This Year
N/A
$6,983.06
Revenue Next Year
$70.61
$36.05
P/E Ratio
N/A
N/A
Revenue Growth
3.20
N/A
52 Week Low
$4.44
$1.30
52 Week High
$58.30
$3.16

Technical Indicators

Market Signals
Indicator
SQNS
ADAG
Relative Strength Index (RSI) 41.85 46.32
Support Level $4.84 $1.75
Resistance Level $4.88 $1.83
Average True Range (ATR) 0.29 0.09
MACD 0.04 -0.00
Stochastic Oscillator 39.11 30.95

Price Performance

Historical Comparison
SQNS
ADAG

About SQNS Sequans Communications S.A.

Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: